Examples of using Open-label in English and their translations into German
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
Single-arm open-label studies.
Design: randomised, global multicentre, open-label.
Study ENB-009-10 was an open-label, randomised study.
An open-label, single-arm, multicentre study was conducted in patients intolerant or resistant to imatinib.
In CHARM, 854 patients received open-label 80 mg at week 0 and 40 mg at week 2.
Double-blind, randomised, placebo-controlled, except for studies C212 and HPC3011 which were open-label, single arm.
LEOPOLD Kids is an open-label, non-randomized Phase III study.
Patients receiving placebo who experienced disease progression were offered open-label regorafenib cross-over option.
COMFORT-II was an open-label, randomised study in 219 patients.
However, patients completing STRIDE-2 were eligible to enrol in open-label studies STRIDE-2X and STRIDE-3.
This study was an open-label, non-randomized, one-arm, 24-month study extension of the Sansika Study.
In between these periods, all patients received open-label Numient treatment for 1 week.
Study PX-171-011 was an open-label randomised phase 3 study N 315; exposure to≥ 3 prior therapies required.
Long term safety in this population was explored in a 50-week, open-label, uncontrolled extension study.
MOR202 is currently in a phase 1/2a, open-label, multi-center, dose-escalation clinical study conducted in several sites in Germany and Austria.
Patients, who had previously completed the 12-monthRESTORE study, were enrolled in the open-label, multicentre.
An additional group received open-label interferon beta-1a 30 mcg IM weekly.
The effect of multiple doses of Arzerra on the QTcinterval was evaluated in a pooled analysis of three open-label studies in patients with CLL N=85.
An open-label, randomised, non-comparative multicentre study was conducted in patients who failed initial treatment with 400 or 600 mg imatinib.
Investigator-initiated, prospective, randomized, open-label, multi-center trial with two parallel groups.
AI444043 was an open-label, single-arm study of daclatasvir with pegIFN/RBV in treatment-naïve adults with chronic HCV genotype 1 infection who were co-infected with HIV.
Of the patients who completed the study who were originally randomised to placebo+ MTX,86% received open-label tocilizumab 8 mg/kg in year 2.
Bosentan film-coated tablets were evaluated in an open-label uncontrolled study in 19 paediatric patients with pulmonary arterial hypertension aged 3to 15 years.
The serious adverse reaction of anaphylactic reaction was reported and considered related to reslizumab in 3 patients(0.19%) during placebo-controlled and open-label asthma studies.
Study 02607 was a randomized, open-label, active-controlled, non-inferiority, multicenter clinical study in 159 patients previously stabilised with ERT.
Two randomised, open-label Phase III studies were conducted to evaluate the efficacy of dasatinib administered once daily compared with dasatinib administered twice daily.
The 4-week, double-blind period was followed by an 8-week, open-label period during which methylnaltrexone bromide was to be used as needed, but no more frequently than once daily.
An open-label, multicentre, international, randomised phase III study supports the use of vemurafenib in previously untreated patients with BRAF V600E mutation-positive unresectable or metastatic melanoma.
The J-ALEX study conducted by Chugai is an open-label, randomised Phase III study that compared the efficacy and safety of Alecensa to crizotinib in Japanese people.
In an open-label non-controlled study, 37 patients with proven or probable mucormycosis received isavuconazole at the same dose regimen as that used to treat invasive aspergillosis.
